PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed (PETS) Surpasses Q2 Earnings Estimates
PetMed (PETS) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to break-even earnings per share a year ago.
Here's Why PetMed (PETS) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why PetMed (PETS) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q1 2025 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR Sandra Campos - Chief Executive Officer & President Christine Chambers - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Operator Greetings and welcome to PetMed Express First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pets at Home's veterinary offering drives revenue growth
Pets at Home Group PLC (LSE:PETS) is seeing a noticeable increase in average spend and visits for its veterinary services, which is helping to offset a decline in retail spend. Vet Group revenues surged more than 17% in the first half of its 2025 financial year, leading to a 1% growth in group-wide revenues to £441.1 million despite a 0.8% dip in retail sales.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS
NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PetMed Express, Inc. (PETS) Q4 2024 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS ) Q4 2024 Earnings Conference Call June 11, 2024 4:30 PM ET Company Participants John Mills - Investor Relations, ICR Sandra Campos - Chief Executive Officer and President Christine Chambers - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Erin Wright - Morgan Stanley Operator Greetings and welcome to PetMed Express Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pets At Home Purrs As FY Profits Meet Updated Guidance
Pets at Home was one of the FTSE 250's best performers on Wednesday, as the retailer announced full-year results in line with January's downgraded guidance.
Pets at Home holds dividend and launches buyback, but sales slip in new year
Pets at Home Group PLC (LSE:PETS) announced plans for new £25 million share buyback after what it said was a "foundational year" as sales growth slowed less than expected in the final quarter. Largely the preliminary results for the 52 weeks to 28 March were in line with pre-announced guidance from the pets-and-vets chain.
Pets at Home's finals all about outlook on squeezed consumer spending
Pets at Home Group PLC (LSE:PETS) reports on Wednesday, 29 May, after scaling back profit guidance in March on squeezed consumer spending. Pre-tax profit guidance of £132 million was laid out in late March, against £136 million previously, as growth in its retail business was slower than expected in the third quarter.
